Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Public Health|July 14, 2024
Detection and disclosure of workplace mental health challenges: an exploratory study from IndiaAnkur Poddar, Raina Chhajer
Frontiers in Microbiology|January 26, 2018
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in VivoRahul Shukla, Ravi K Rajpoot, Upasana Arora, et al.
The American Journal of Tropical Medicine and Hygiene|November 9, 2016
Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing AntibodiesNiyati Khetarpal, Rahul Shukla, Ravi Kant Rajpoot, et al.
BMC Biotechnology|June 16, 2016
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodiesAnkur Poddar, Viswanathan Ramasamy, Rahul Shukla, et al.
Expert Review of Vaccines|December 28, 2018
Next generation designer virus-like particle vaccines for dengueRahul Shukla, Viswanathan Ramasamy, Ravi Kant Rajpoot, et al.
Frontiers in Microbiology|October 7, 2015
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodiesLav Tripathi, Shailendra Mani, Rajendra Raut, et al.
Ebiomedicine|September 19, 2020
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse modelsRahul Shukla, Hemalatha Beesetti, Julia A Brown, et al.
Journal of Nanobiotechnology|May 28, 2013
Dengue-specific subviral nanoparticles: design, creation and characterizationNiyati Khetarpal, Ankur Poddar, Satish K Nemani, et al.
Plos Neglected Tropical Diseases|January 9, 2018
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 miceViswanathan Ramasamy, Upasana Arora, Rahul Shukla, et al.
Diabetes Care|June 10, 2019
Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled StudyPreeshila Behary, George Tharakan, Kleopatra Alexiadou, et al.
Pageof 2